P2RX7 and Keratoconjunctivitis sicca: While the P2X7-induced boost in the exocytotic capability is a high-gain benefit that helps resolve ocular dryness/hyperosmolarity, recent evidence also demonstrates that P2X7 activation carries high-risk due to its impact on the inflammatory processes and the goblet cell death that are closely associated with progression to irreversible dry eye.